new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Sigma tau Industrie Farmaceutiche Riunite S p a patents

Recent patent applications related to Sigma tau Industrie Farmaceutiche Riunite S p a. Sigma tau Industrie Farmaceutiche Riunite S p a is listed as an Agent/Assignee. Note: Sigma tau Industrie Farmaceutiche Riunite S p a may have other listings under different names/spellings. We're not affiliated with Sigma tau Industrie Farmaceutiche Riunite S p a, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sigma tau Industrie Farmaceutiche Riunite S p a-related inventors




Date Sigma tau Industrie Farmaceutiche Riunite S p a patents (updated weekly) - BOOKMARK this page
10/27/16Compounds useful for increasing neurogenesis in neural tissue
10/20/16Composition useful for promoting female fertility
09/01/165-beta, 14-beta-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure
01/07/16Oxidated derivatives of triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
09/10/15Modified hyaluronic acid derivatives and use thereof
02/12/15Composition useful for the treatment of type 2 diabetes
10/02/14Compound with antibacterial activity
09/11/14Composition useful for the prevention or reduction of the progression of prostate cancer
07/17/14Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline
05/15/14Pharmaceutical composition of oxidised avidin suitable for inhalation
03/27/14Inner tube
03/27/14Composition useful for the treatment of lipid metabolism disorders
03/20/14Compounds useful for the prevention or treatment of accommodative asthenopia
02/20/14Therapeutical the treatment of the leber optic neuropathy
01/23/14Acetyl l-carnitine for the preparation of a medicament for the prevention of painful peripheral neuropathy in patients with type 2 diabetes
01/16/14Combination composition, comprising as active ingredients l-carnitlne or propionyl l-carnitlne, for the prevention or treatment of chronic venous insufficiency
11/21/13Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
11/21/13Diterpenoid derivatives endowed of biological properties
08/08/13Compounds useful for increasing neurogenesis in neural tissue
05/30/13Gel useful for the delivery of ophthalmic drugs
02/21/13Composition comprising as active ingredient l-carnitine in combination with a solar filter, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
01/03/13Combination composition, comprising as active ingredients l-carnitlne or propionyl l-carnitlne, for the prevention or treatment of chronic venous insufficiency
10/11/12Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
10/11/12Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
10/04/12Carbamate derivatives in particular for the treatment of neurological disorders
08/16/12Treatment of oncological diseases
04/19/12Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
02/16/12Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
11/03/11Compounds useful for the prevention or treatment of accomodative asthenopia
10/27/11Composition useful for the prevention or reduction of the progression of prostate cancer
09/08/11Compound useful for treating cellulite
08/04/11Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
06/30/11Novel dual targeting antitumoral conjugates
06/09/11Crystalline teglicar
04/14/11Use of l-carnitine for the treatment of cardiovascular diesases
03/03/11Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
12/30/10Combination of a retinoid and a platinum anticancer agent
12/23/10Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
12/02/105beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/10Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
11/25/10Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
09/30/10Crystalline form ii of 7-(dimethoxy-methyl) camptothecin, its use as intermediate and products obtained therefrom
09/23/10Oxidized avidin with high residency time in the treated tissues
08/19/10Deglycosylated and desialidated long pentraxin ptx3
08/05/10Treatment of pediatric tumors
07/29/10Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
07/22/10Synthesis of deoxybiotinyl hexamethylenediamine-dota
07/01/10Pharmaceutical composition comprising a campothecin derivative
05/06/10Amide compounds and their use as antitumor agents
04/15/10Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
03/18/10Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
03/18/10Gel useful for the delivery of ophthalmic drugs
02/25/10Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
02/25/10Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
02/04/10Composition useful for the treatment of type 2 diabetes
12/17/09Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
11/05/09Use of thymosin alpha 1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
11/05/09Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
10/15/09Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract
09/24/09Stereoselective process and crystalline forms of a camptothecin
09/03/09Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
07/23/09Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
06/18/09Use of thymosin alpha 1 for the treatment of immunological diseases
06/04/09Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
05/28/09Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
Patent Packs
05/21/09Combination of antidiabetic drugs
03/19/09Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome
03/05/09Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sigma tau Industrie Farmaceutiche Riunite S p a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sigma tau Industrie Farmaceutiche Riunite S p a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';